Comparison of sacral erector spinae plane block and caudal epidural block for postoperative analgesia in pediatric hypospadias surgery: a prospective observational study Authors: Sümeyye Kankal, Mert Bozdana, Engin İhsan Turan, Bahadır Çiftçi, Volkan Özen Published: 2026 ABSTRACT BackgroundEffective postoperative analgesia is essential in pediatric urogenital surgery to reduce stress responses and opioid exposure. Caudal epidural block is widely used for hypospadias repair; however, its duration may be limited and it is associated with neuraxial-related concerns. Sacral erector spinae plane (ESP) block has recently emerged as a potential alternative regional technique. This study aimed to compare the analgesic efficacy of sacral ESP block and caudal epidural block in children undergoing hypospadias surgery.MethodsThis prospective, comparative observational study included 86 pediatric patients (aged 1–7 years, ASA I–II) undergoing elective hypospadias repair. Patients were allocated to receive either ultrasound-guided sacral ESP block or landmark-based caudal epidural block with 0.5 mL·kg⁻1 of 0.25% bupivacaine. Postoperative pain was assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at 1, 2, 4, 6, 12, and 24 h postoperatively by a blinded observer. The primary outcome was FLACC score at postoperative 12 h. Secondary outcomes included pain scores at other time points, time to first rescue analgesic, postoperative analgesic consumption, and block-related complications.ResultsEighty-six patients were analyzed (43 per group), with no significant differences in baseline characteristics. Median FLACC scores were significantly lower in the sacral ESP group at all postoperative time points, including the primary endpoint at 12 h (0 [0–0] vs. 1 [0–2], p < 0.001). Time to first rescue analgesic was significantly longer in the sacral ESP group (mean 22.7 h, 95% CI 21.5–23.9) compared with the caudal group (13.7 h, 95% CI 10.9–16.6; p < 0.001). The median number of postoperative analgesic administrations was lower in the sacral ESP group (0 [0–0] vs. 1 [0–1], p < 0.001). No block-related complications were observed in either group.ConclusionsUltrasound-guided sacral erector spinae plane block was associated with lower postoperative pain scores, prolonged time to rescue analgesia, and reduced analgesic consumption compared with caudal epidural block in pediatric patients undergoing hypospadias surgery. Sacral ESP block may represent a useful alternative to caudal epidural block; however, randomized controlled studies are required to confirm these findings.Trial registrationClinicalTrials.gov, NCT07286786. Introduction Effective postoperative pain management in pediatric patients is a fundamental component of perioperative care, as inadequate analgesia is associated with increased stress responses, delayed recovery, behavioral disturbances, and higher analgesic requirements (Olejnik et al. 2025). Children undergoing urogenital surgeries, such as hypospadias repair, frequently experience moderate to severe postoperative pain, which may be difficult to assess and manage due to age-related communication limitations. Given the potential adverse effects of systemic opioids, regional anesthesia techniques play a central role in providing effective and opioid-sparing postoperative analgesia in pediatric surgery (Barnett et al. 2024). Caudal epidural block has long been considered the standard regional anesthesia technique for infraumbilical and urogenital procedures in children. Its widespread use is supported by a well-established analgesic profile, relative technical simplicity, and familiarity among anesthesiologists. However, caudal block is not without limitations, including variable duration of analgesia, risk of motor blockade, urinary retention, and concerns regarding infection or inadvertent intravascular injection. In addition, the analgesic effect of a single-shot caudal block may be insufficient to cover the entire postoperative period, particularly in procedures associated with prolonged or moderate pain intensity. The erector spinae plane (ESP) block has emerged as a novel interfascial plane block providing effective analgesia in a variety of surgical settings (Aksu and Gürkan 2020; Tulgar et al. 2019). Recently, sacral applications of the erector spinae plane block have been proposed as an alternative regional technique for pediatric infraumbilical surgery (Mendes et al. 2025). By targeting the dorsal rami and allowing potential spread to ventral sacral nerve roots, sacral erector spinae plane block may provide effective analgesia while minimizing some of the limitations associated with neuraxial techniques (Özen et al. 2024, 2025; Dost et al. 2025). However, evidence comparing sacral erector spinae plane block with established techniques such as caudal epidural block in pediatric urogenital surgery remains limited, and direct comparative data are scarce. The present prospective observational study was designed to compare the analgesic efficacy of sacral erector spinae plane block and caudal epidural block in pediatric patients undergoing hypospadias surgery. The primary hypothesis was that sacral ESP block would be associated with lower FLACC pain scores at postoperative 12 h. Methods Ethics This prospective comparative observational study was approved by the Institutional Clinical Research Ethics Committee (Approval No: E-48670771–514.99–266,741,044) and registered at ClinicalTrials.gov (Identifier: NCT07286786). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written and verbal informed consent was obtained from the parents or legal guardians of all participants after detailed explanation of the study protocol. Study population The study was conducted between January 2025 and August 2025. Pediatric patients aged 1–7 years with American Society of Anesthesiologists (ASA) physical status I–II, scheduled for elective hypospadias repair under general anesthesia, were assessed for eligibility. Inclusion criteria were planned primary hypospadias surgery within the defined age range, provision of written informed consent by a legal guardian, and absence of contraindications to regional anesthesia. Exclusion criteria included parental refusal, infection at the injection site, coagulopathy, congenital spinal anomalies, neuromuscular disease, or known allergy to local anesthetics. Group allocation This study was designed as a prospective observational study, and no randomization was performed. The choice of regional anesthesia technique (sacral ESP block or caudal epidural block) was determined by the attending anesthesiologist based on clinical preference, experience, and routine institutional practice at the time of surgery. To minimize selection bias, consecutive eligible patients during the study period were included without predefined selection criteria for either technique. No protocol-driven assignment was applied. Given the non-randomized design, the potential for selection bias and residual confounding was acknowledged and considered in the interpretation of the results. Blinding The anesthesiologist performing the block was aware of group allocation, whereas postoperative pain assessments were performed by an independent observer blinded to the group assignments to minimize assessment bias. Anesthesia protocol All patients followed standard pediatric fasting guidelines. Oral midazolam (0.5 mg·kg⁻1) was administered as premedication 30 min before surgery. Standard monitoring included heart rate, non-invasive blood pressure, pulse oximetry, and core temperature. Anesthesia induction was achieved with sevoflurane (4–8%) in 100% oxygen, followed by intravenous propofol (3 mg·kg⁻1) and fentanyl (1 µg·kg⁻1). A supraglottic airway device appropriate to body weight was inserted, and mechanical ventilation was initiated with a tidal volume of 8 mL·kg⁻1, adjusting respiratory rate to maintain end-tidal CO₂ between 35 and 40 mmHg. Anesthesia was maintained with sevoflurane. All patients underwent hypospadias repair using the tubularized incised plate urethroplasty (TIPU) technique. Intravenous paracetamol (15 mg·kg⁻1) was administered 10 min before the end of surgery. Regional block techniques After induction of anesthesia and before surgical incision, patients were positioned in the lateral decubitus position under sterile conditions. ESP blocks were performed under ultrasound guidance using a Mindray DC-7 ultrasound system with a high-frequency linear probe (5–10 MHz). All blocks were performed by experienced anesthesiologists routinely performing pediatric regional anesthesia. Standard aseptic techniques were used, and negative aspiration was performed prior to injection to minimize the risk of intravascular administration. Sacral ESP block The ultrasound probe was placed in the sagittal plane over the sacral midline to identify the median sacral crests and erector spinae muscles. A 22-G, 50-mm block needle was advanced in a cranio-caudal direction to the fascial plane deep to the erector spinae muscle at the level of the fourth median sacral crest. After negative aspiration, 0.5 mL·kg⁻1 of 0.25% bupivacaine was injected incrementally (Fig. 1).Fig. 1Application of sacral erector spinae plane block. LA: Local Anesthetic Application of sacral erector spinae plane block. LA: Local Anesthetic Caudal epidural block The sacral cornua were identified by palpation, and a 22-G needle was inserted through the sacrococcygeal membrane using a landmark-based technique. Following negative aspiration, 0.5 mL·kg⁻1 of 0.25% bupivacaine was administered incrementally. Postoperative monitoring and analgesia Patients were monitored in the post-anesthesia care unit and subsequently transferred to the pediatric ward for 24-h observation. Postoperative pain was assessed using the FLACC scale at 1, 2, 4, 6, 12, and 24 h postoperatively by a blinded observer. Rescue analgesia consisted of intravenous paracetamol (10 mg·kg⁻1) administered for FLACC scores > 3 and intravenous ibuprofen (10 mg·kg⁻1) administered for FLACC scores > 5. All analgesic consumption and adverse events were recorded. Rescue analgesia was administered according to predefined FLACC thresholds by nursing staff, and the protocol was consistently applied throughout the study period. Nursing staff were not involved in group allocation. Variables and outcomes Demographic variables included age, sex, weight, and ASA physical status. Intraoperative variables included hemodynamic parameters and complications. Primary outcome: Comparison of FLACC pain scores at 12 h. Secondary outcomes: FLACC pain scores at 1, 2, 4, 6, and 24 h postoperatively, postoperative analgesic consumption within the first 24 h, and block-related complications. Adverse events actively assessed included vascular puncture, block failure, motor weakness, urinary retention, nausea/vomiting, local anesthetic systemic toxicity, infection, and delayed discharge. Statistical analysis and sample size Statistical analyses were performed using SPSS version 26.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were assessed for normality using visual inspection of histograms and the Shapiro–Wilk test. Normally distributed continuous variables are presented as mean ± standard deviation and were compared between groups using the independent samples t-test. Categorical variables are presented as number (percentage) and were compared using Fisher’s exact test. FLACC pain scores at each postoperative time point are presented as median (interquartile range) and were compared between groups using the Mann–Whitney U test due to non-normal distribution. To account for repeated measurements over time, between-group comparisons across all postoperative time points were additionally analyzed using a generalized linear mixed model, which accounts for within-subject correlations and allows longitudinal comparison between groups, with Bonferroni correction applied to adjust for multiple comparisons. Time to first rescue analgesic was analyzed using the Kaplan–Meier method, and between-group differences were assessed with the log-rank test. The median time to event was reported when estimable; otherwise, censoring proportions were provided. The number of postoperative analgesic administrations is presented as median (interquartile range) and was compared using the Mann–Whitney U test. Bootstrap 95% confidence intervals for medians were calculated using percentile resampling. A sensitivity analysis restricted to ASA I patients was performed. A two-sided p value < 0.05 was considered statistically significant. Sample size calculation A priori sample size estimation was performed based on the primary outcome, the FLACC score at postoperative 12 h. In a preliminary analysis including 10 patients per group, the mean ± standard deviation (SD) FLACC score was 0.4 ± 0.51 in the ESP block group and 0.9 ± 0.73 in the caudal block group. Based on this difference, a two-sided α level of 0.05 and a statistical power of 95% were assumed. According to the power analysis, a minimum of 43 patients per group was required to detect a statistically significant difference between groups. Therefore, 43 patients were planned to be included in each group. Results Totally 86 patients were included in this study (Fig. 2.) Table 1 presents the baseline clinical characteristics of the patients. The mean age was 30.98 ± 23.38 months in the caudal group and 36.56 ± 20.40 months in the ESP group (p = 0.242). Mean body weight was 13.48 ± 5.09 kg and 13.59 ± 4.38 kg, respectively (p = 0.919). The distribution of ASA physical status (I/II) was 38/5 in the caudal group and 43/0 in the ESP group (p = 0.055).Fig. 2Flow diagram of patientsTable 1Clinical characteristics of the patientsCaudal Group (n = 43)ESP Group (n = 43)p valueAge (months)30.98 ± 23.3836.56 ± 20.400.242*Weight (kg)13.48 ± 5.0913.59 ± 4.380.919*ASA Scores (I/II)38/543/00.055**Data are presented as n or mean ± standard deviation*Independent samples t-test have been used**Fisher’s exact test has been used Flow diagram of patients Table 1Clinical characteristics of the patientsCaudal Group (n = 43)ESP Group (n = 43)p valueAge (months)30.98 ± 23.3836.56 ± 20.400.242*Weight (kg)13.48 ± 5.0913.59 ± 4.380.919*ASA Scores (I/II)38/543/00.055**Data are presented as n or mean ± standard deviation*Independent samples t-test have been used**Fisher’s exact test has been used Clinical characteristics of the patients Data are presented as n or mean ± standard deviation *Independent samples t-test have been used **Fisher’s exact test has been used Table 2 shows the comparison of FLACC scores between the groups at different postoperative time points. At 1 h, the median FLACC score was 1 (0–2) in Group 1 and 0 (0–0) in Group 2 (p < 0.001). At 2 h, median scores were 1 (0–2) and 0 (0–0), respectively (p < 0.001). At 4 h, the median FLACC score was 1 (1–3) in Group 1 and 0 (0–0) in Group 2 (p < 0.001). At 6 h, median scores were 2 (1–3.5) in Group 1 and 0 (0–0) in Group 2 (p < 0.001). At 12 h, median FLACC scores were 1 (0–2) and 0 (0–0), respectively (p < 0.001). At 24 h, median scores were 0 (0–1) in Group 1 and 0 (0–0) in Group 2 (p < 0.001).Table 2Comparison of FLACC score between groupsCaudal Group (n = 43) Median (IQR)ESP Group 2(n = 43) Median (IQR)Mann–Whitney Up value1 h1 (0–2)0 (0–0)387.0 < 0.0012 h1 (0–2)0 (0–0)258.0 < 0.0014 h1 (1–3)0 (0–0)107.5 < 0.0016 h2 (1–3.5)0 (0–0)243.0 < 0.00112 h1 (0–2)0 (0–0)504.5 < 0.00124 h0 (0–1)0 (0–0)494.5 < 0.001Data are presented as median (interquartile range). Between-group comparisons at each time point were performed using the Mann–Whitney U test Table 2Comparison of FLACC score between groupsCaudal Group (n = 43) Median (IQR)ESP Group 2(n = 43) Median (IQR)Mann–Whitney Up value1 h1 (0–2)0 (0–0)387.0 < 0.0012 h1 (0–2)0 (0–0)258.0 < 0.0014 h1 (1–3)0 (0–0)107.5 < 0.0016 h2 (1–3.5)0 (0–0)243.0 < 0.00112 h1 (0–2)0 (0–0)504.5 < 0.00124 h0 (0–1)0 (0–0)494.5 < 0.001Data are presented as median (interquartile range). Between-group comparisons at each time point were performed using the Mann–Whitney U test Comparison of FLACC score between groups Data are presented as median (interquartile range). Between-group comparisons at each time point were performed using the Mann–Whitney U test Between-group comparisons across repeated time points were additionally analyzed using a generalized linear mixed model with Bonferroni correction, which confirmed a statistically significant difference between groups (adjusted p < 0.001). Table 3 presents the time to first rescue analgesic and postoperative analgesic use. The mean time to first rescue analgesic was 13.7 h (95% CI, 10.9–16.6) in the caudal group and 22.7 h (95% CI, 21.5–23.9) in the ESP group (p < 0.001). The median time to first rescue analgesic was 12.0 h in the caudal group, whereas it was not estimable in the ESP group due to censoring. The proportion of censored observations was 39.5% in the caudal group and 90.7% in the ESP group.Table 3Time to first rescue analgesic and postoperative analgesic useCaudal group (n = 43)ESP group (n = 43)p valueTime to first rescue analgesic (hours) Mean time, 95% CI13.7 (10.9–16.6)22.7 (21.5–23.9) < 0.001* Median time (h)12.0Not estimable Censored (%)39.590.7Postoperative analgesic administrations Number of administrations, median (IQR)1 (0–1)0 (0–0) < 0.001 Median (95% bootstrap CI)1 (0–1)0 (0–0) Table 3Time to first rescue analgesic and postoperative analgesic useCaudal group (n = 43)ESP group (n = 43)p valueTime to first rescue analgesic (hours) Mean time, 95% CI13.7 (10.9–16.6)22.7 (21.5–23.9) < 0.001* Median time (h)12.0Not estimable Censored (%)39.590.7Postoperative analgesic administrations Number of administrations, median (IQR)1 (0–1)0 (0–0) < 0.001 Median (95% bootstrap CI)1 (0–1)0 (0–0) Time to first rescue analgesic and postoperative analgesic use The median number of postoperative analgesic administrations was 1 (0–1) in the caudal group and 0 (0–0) in the ESP group (p < 0.001). The median values with 95% bootstrap confidence intervals were 1 (0–1) and 0 (0–0), respectively. Time-to-event analysis was performed using the Kaplan–Meier method, and between-group comparisons were conducted using the log-rank test. Median time was not estimable in the ESP group due to a high proportion of censored observations. Analgesic administration counts are presented as median (interquartile range) and were compared using the Mann–Whitney U test. Bootstrap confidence intervals were calculated using percentile resampling. Similar results were observed in the sensitivity analysis including only ASA I patients (Table 4).Table 4Sensitivity analysis for ASA scoresCaudal Group (n = 38) Median (Q1–Q3)ESP Group (n = 43) Median (Q1–Q3)p valueFLACC 1 h1 (0–2)0 (0–0) < 0.001FLACC 2 h1 (0–2)0 (0–0) < 0.001FLACC 4 h1.5 (1–3)0 (0–0) < 0.001FLACC 6 h2 (1–3)0 (0–0) < 0.001FLACC 12 h1 (0–2)0 (0–0) < 0.001FLACC 24 h0 (0–1)0 (0–0) < 0.001Time to first analgesia (h)12 (4–24)24 (24–24) < 0.001 Table 4Sensitivity analysis for ASA scoresCaudal Group (n = 38) Median (Q1–Q3)ESP Group (n = 43) Median (Q1–Q3)p valueFLACC 1 h1 (0–2)0 (0–0) < 0.001FLACC 2 h1 (0–2)0 (0–0) < 0.001FLACC 4 h1.5 (1–3)0 (0–0) < 0.001FLACC 6 h2 (1–3)0 (0–0) < 0.001FLACC 12 h1 (0–2)0 (0–0) < 0.001FLACC 24 h0 (0–1)0 (0–0) < 0.001Time to first analgesia (h)12 (4–24)24 (24–24) < 0.001 Sensitivity analysis for ASA scores Discussion In this prospective observational study, sacral erector spinae plane block was associated with improved postoperative analgesic outcomes compared with caudal epidural block in pediatric patients undergoing hypospadias surgery. Patients receiving sacral ESP block experienced lower postoperative pain scores across all assessed time points, a delayed need for rescue analgesia, and reduced overall postoperative analgesic use. These findings indicate a longer-lasting analgesic effect of sacral ESP block within the first postoperative day. Both regional techniques were well tolerated, with no clinically relevant block-related complications observed. Our findings align with the recent systematic review and meta-analysis by (Kozanhan et al. 2025), which demonstrated that sacral ESP block prolongs postoperative analgesia and reduces 24-h analgesic consumption in pediatric infraumbilical surgeries compared with caudal and other regional techniques. While that meta-analysis showed a clear benefit in time to first rescue analgesia but inconsistent differences in early postoperative FLACC scores, our procedure-specific comparison in children undergoing hypospadias repair revealed both a markedly delayed need for rescue analgesia and consistently lower FLACC scores at all postoperative time points, including the predefined 12-h primary endpoint. This discrepancy is likely attributable to the reduced clinical heterogeneity and standardized perioperative analgesic protocol in our study. In contrast, (Sancak Demirci et al. 2025), reported longer analgesic duration and lower pain scores with caudal block; however, differences in local anesthetic dosing, sacral ESP injection technique, and postoperative analgesic protocols may explain these conflicting results, underscoring the technique- and protocol-dependent nature of sacral ESP block efficacy. Importantly, concerns regarding caudal block–related surgical complications are mitigated by the meta-analysis of (Xia et al. 2024), which demonstrated no association between caudal block and urethrocutaneous fistula or glans dehiscence, a finding consistent with the absence of block-related complications in our cohort. Furthermore, our results are supported by the randomized controlled trial by (Bansal et al. 2024), which showed that sacral ESP block significantly reduced postoperative analgesic consumption and prolonged time to first rescue analgesia compared with no-block controls. Finally, although a broader meta-analysis comparing ESP block and caudal block across heterogeneous pediatric abdominal surgeries found no significant differences in analgesic efficacy (Masiero et al. 2025), the substantial heterogeneity highlighted by the authors suggests that procedure-specific applications, such as sacral ESP block in hypospadias surgery, may reveal clinically meaningful advantages that are obscured in pooled analyses. Taken together, the available evidence suggests that sacral ESP block is a safe and clinically useful alternative to caudal epidural block, although further randomized studies are needed to confirm comparative efficacy. Recent clinical studies further support the analgesic efficacy and versatility of sacral ESP block across different pediatric urogenital procedures. In a prospective, randomized, multicenter trial, (Satıcı et al. 2025) demonstrated that S-ESPB provided significantly lower FLACC pain scores at all postoperative time points compared with ring block following circumcision surgery, alongside reduced rescue analgesic requirements and prolonged analgesic duration. Although circumcision differs from hypospadias repair in surgical extent and tissue involvement, these findings reinforce the concept that sacral ESP block offers robust and consistent postoperative analgesia in pediatric penile surgeries, supporting its role as an effective alternative to more localized peripheral techniques such as ring block. In addition to comparative efficacy, optimization of sacral ESP block technique and dosing has been explored. In a double-blind randomized trial, (Bansal et al. 2025) showed that reducing bupivacaine concentration from 0.25% to 0.125% while maintaining volume did not compromise analgesic efficacy in children undergoing hypospadias repair, suggesting that sacral ESP block functions as a volume-dependent interfascial block and may be safely performed with lower local anesthetic doses. Furthermore, emerging sacral interfascial techniques, such as the ultrasound-guided sacral multifidus plane block described by (Mahajan et al. 2021) in neonates undergoing sacrococcygeal teratoma excision, highlight the expanding applicability of sacral plane blocks in situations where neuraxial techniques are contraindicated. Collectively, these studies support the safety, adaptability, and analgesic effectiveness of sacral fascial plane blocks and further contextualize our findings, indicating that the superior analgesic profile observed with sacral ESP block in hypospadias surgery is consistent with broader pediatric experience across different procedures, techniques, and anesthetic concentrations. Although the difference in FLACC scores at the primary endpoint (12 h) was statistically significant, the absolute difference was small, and both groups demonstrated relatively low pain scores. Therefore, the clinical significance of this finding should be interpreted with caution. Notably, the ESP group also showed a significantly prolonged time to first rescue analgesia and reduced analgesic consumption, which may support the clinical relevance of the observed differences. This study has several limitations. First, the design was observational and single-center, which may limit external validity and generalizability to other institutions, surgical teams, and perioperative analgesic protocols. In addition, the non-randomized allocation of patients represents an inherent limitation of the study design. The choice of block technique was based on clinician preference rather than random assignment, which may introduce selection bias and residual confounding. Although baseline characteristics were largely comparable between groups, unmeasured factors may have influenced both group allocation and outcomes. Therefore, the results should be interpreted as associative rather than causal. Second, the anesthesiologist performing the block was not blinded, introducing potential performance bias; however, postoperative pain assessments were conducted by a blinded observer to mitigate detection bias. Third, caudal block was performed using a landmark-based technique rather than ultrasound guidance, which may have influenced block success and duration compared with an image-guided approach, potentially introducing performance bias in favor of the ESP group. Importantly, this comparison reflects real-world clinical practice, where ultrasound-guided and landmark-based techniques are commonly used rather than strictly equivalent technical conditions.Fourth, we did not objectively confirm block spread or sensory distribution (e.g., dermatomal mapping), and we did not formally assess motor block, urinary retention, or parental satisfaction, which could provide additional clinically relevant comparative information. Additionally a numerical imbalance in ASA physical status between groups may represent a potential source of confounding, although all patients were classified as ASA I–II. Finally, although no block-related complications were observed, the sample size was relatively small and not powered to reliably detect rare adverse events; therefore, larger multicenter trials are warranted to confirm safety and reproducibility. In children undergoing hypospadias repair, sacral erector spinae plane block was associated with lower postoperative FLACC scores, prolonged time to first rescue analgesia, and reduced analgesic consumption compared with caudal epidural block. Both techniques were well tolerated in this cohort. Given the observational design, these findings should be interpreted with caution, and randomized controlled studies are required to confirm comparative efficacy.